Scientists at Columbia University have developed a microneedle capable of safely delivering medication to the cochlea of the inner ear and collecting fluid samples for diagnostic purposes. This breakthrough, achieved using two-photon lithography, minimizes damage to the cochlear membrane, which is as thin as a human hair. In animal trials, the prototype showed no adverse effects on hearing, and the membrane healed within two days after the procedure.
The cochlea, a spiral-shaped fluid-filled structure, poses significant challenges for conventional surgical drug delivery methods. Damage to its delicate membrane, which must be penetrated to reach target cells, can lead to complete hearing loss and balance issues. The newly designed microneedle reduces these risks by creating a tiny puncture just large enough for precise drug delivery or fluid collection. This precision is particularly valuable for diagnosing and treating conditions like Meniere’s disease.
The development of the microneedle was guided by an analysis of the membrane’s strength, likened to a taut tarp: a small puncture is safe, but a larger one risks tearing. Leveraging high-resolution 3D printing, researchers crafted needles with a smaller diameter and sharper point than conventional medical tools.
This innovation paves the way for new treatments for inner ear disorders, including gene therapy aimed at restoring hearing. Researchers believe the technology will lead to more effective diagnostic and therapeutic methods, revolutionizing the management of audiological conditions.
#space #science #educational #technology
